89 related articles for article (PubMed ID: 11748299)
1. Improved detection of substantia nigra pathology in Alzheimer's disease.
Schneider JA; Bienias JL; Gilley DW; Kvarnberg DE; Mufson EJ; Bennett DA
J Histochem Cytochem; 2002 Jan; 50(1):99-106. PubMed ID: 11748299
[TBL] [Abstract][Full Text] [Related]
2. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
[TBL] [Abstract][Full Text] [Related]
3. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
[TBL] [Abstract][Full Text] [Related]
4. Brainstem and cortical Lewy bodies in patients presenting clinically with Alzheimer's disease.
SantaCruz KS; Tasaki CS; Kim RC; Cotman CW
J Alzheimers Dis; 2002 Feb; 4(1):11-7. PubMed ID: 12214014
[TBL] [Abstract][Full Text] [Related]
5. A novel fluorescent method for direct visualization of neurofibrillary pathology in Alzheimer's disease.
Sun A; Nguyen XV; Bing G
J Neurosci Methods; 2001 Oct; 111(1):17-27. PubMed ID: 11574116
[TBL] [Abstract][Full Text] [Related]
6. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunohistochemical study.
Szpak GM; Lewandowska E; Lechowicz W; Bertrand E; Wierzba-Bobrowicz T; Gwiazda E; Pasennik E; Kosno-Kruszewska E; Lipczyńska-Lojkowska W; Bochyńska A; Fiszer U
Folia Neuropathol; 2001; 39(2):63-71. PubMed ID: 11680637
[TBL] [Abstract][Full Text] [Related]
7. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer-type pathology in melanin-bleached sections of substantia nigra.
Uchihara T; Kondo H; Ikeda K; Kosaka K
J Neurol; 1995 Aug; 242(8):485-9. PubMed ID: 8530974
[TBL] [Abstract][Full Text] [Related]
9. Visualization of newly deposited tau in neurofibrillary tangles and neuropil threads.
Miyasaka T; Watanabe A; Saito Y; Murayama S; Mann DM; Yamazaki M; Ravid R; Morishima-Kawashima M; Nagashima K; Ihara Y
J Neuropathol Exp Neurol; 2005 Aug; 64(8):665-74. PubMed ID: 16106214
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections.
Sun A; Nguyen XV; Bing G
J Histochem Cytochem; 2002 Apr; 50(4):463-72. PubMed ID: 11897799
[TBL] [Abstract][Full Text] [Related]
11. Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.
Gearing M; Lynn M; Mirra SS
Arch Neurol; 1999 Feb; 56(2):203-8. PubMed ID: 10025425
[TBL] [Abstract][Full Text] [Related]
12. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
[TBL] [Abstract][Full Text] [Related]
13. Decreased nigral neuromelanin in Alzheimer's disease.
Reyes MG; Faraldi F; Rydman R; Wang CC
Neurol Res; 2003 Mar; 25(2):179-82. PubMed ID: 12635519
[TBL] [Abstract][Full Text] [Related]
14. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders.
Schmidt ML; Martin JA; Lee VM; Trojanowski JQ
Acta Neuropathol; 1996; 91(5):475-81. PubMed ID: 8740227
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of the substantia nigra in Alzheimer's disease.
Reyes MG; Faraldi F; Chandran R; Verano A; Levi AC
Panminerva Med; 1996 Mar; 38(1):8-14. PubMed ID: 8766873
[TBL] [Abstract][Full Text] [Related]
16. Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.
Uchihara T; Kondo H; Kosaka K; Tsukagoshi H
Acta Neuropathol; 1992; 83(3):271-6. PubMed ID: 1373022
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
18. Neuropathology of parkinsonism in patients with pure Alzheimer's disease.
Horvath J; Burkhard PR; Herrmann FR; Bouras C; Kövari E
J Alzheimers Dis; 2014; 39(1):115-20. PubMed ID: 24121968
[TBL] [Abstract][Full Text] [Related]
19. The frequency of Lewy bodies in a consecutive autopsy series.
Lindboe CF; Hansen HB
Clin Neuropathol; 1998; 17(4):204-9. PubMed ID: 9707335
[TBL] [Abstract][Full Text] [Related]
20. 14-3-3 proteins and zeta isoform containing neurofibrillary tangles in patients with Alzheimer's disease.
Umahara T; Uchihara T; Tsuchiya K; Nakamura A; Iwamoto T; Ikeda K; Takasaki M
Acta Neuropathol; 2004 Oct; 108(4):279-86. PubMed ID: 15235803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
